Thank you for your interest in submitting a multiple sclerosis patient case study to the Merck MS Medical Grand Rounds meeting series.

To submit a case for presentation at the upcoming meeting, please complete the form below.

Please note, all cases will be reviewed by the Steering Committee, who will select cases for discussion. Owners of selected cases are welcome to pre-record the presentation of their case, which will be disseminated during the live meeting. Alternatively, cases can be presented and discussed by the Steering Committee, if preferred.

If you have questions at any point, please reach out to the team at MerckGrandRounds@nucleusglobalteams.com

This hybrid meeting entitled 'MS Medical Grand Rounds: Treatment strategies in the real-world' will be led by an expert panel from MENACTRIMS, who will explore treatment strategies in MS and the decision-making behind them.

Example submissions under this theme could include: 
  • Long-term administration of immune reconstitution therapy
  • Administration of chronic immunosuppression
  • The use of MRI and non-imaging biomarkers to guide treatment strategies
  • Treatment considerations for elderly patients and in pregnancy
  • Approaches for COVID-19 booster vaccination and combination of vaccine types
Please provide as much detail as possible while ensuring patient anonymity is maintained.

Thank you for your time in submitting the case study details for the webinar. 

Question Title

* 1. Your details

Question Title

* 2. Patient age:

Question Title

* 3. Patient sex:

Question Title

* 4. Description of case study problem:

Please use the open-text field to describe the main issue for discussion from your chosen case study (e.g. diagnostic query, disease-modifying therapy decision, switching, de-risking, pregnancy, adverse event handling, or any other issue identified). Please make clear how your case aligns with the webinar theme.

At this initial stage, please provide as much contextual detail as possible; should you have any pre-existing supporting documents please attach them here (e.g. case study summary/clinical, radiologic and laboratory assessments).

Should your submitted case be shortlisted for presentation by the Steering Committee, you will be contacted to provide further full case study details (for example, where relevant: MS diagnosis, disease duration, clinical, radiologic and laboratory assessments, and treatment history/outcomes).

Question Title

* Attach file here:

PDF, DOC, DOCX, PNG, JPG, JPEG, GIF file types only.
Choose File

Question Title

* 5. Presentation of case study:

Accepted case study submissions can be presented live during the meeting by our panel on your behalf or submitted as pre-recorded content.

Please could you confirm your preference from the options below:

Terms and conditions of submission

Question Title

* In the collection, processing and transfer (if applicable) of Personal Data and performance of the Case study for presentation at the upcoming Merck MS Grand Rounds webinar, the Parties shall strictly comply with all applicable national, regional, and local Laws relating to protection of Personal Data (the “Data Protection Legislation”), including, without limitation, as applicable, the European Data Protection Directive 95/46/EC and as of May, 25 2018 the European Data Protection Regulation (GDPR) ((Regulation (EU) 2016/679 (“GDPR”)). 

The data collected for the performance of the Case study is fully anonymized. Use of treatments off-label will not be accepted for discussion by the panel.

GL-NONNI-00653 | October 2021

T